Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Concurrent With Radiotherapy vs Radiotherapy in Elderly Esophageal Cancer
NCT02813967Phase 3Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jun 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Zhejiang Cancer Hospital. Started Jun 2016; status: completed.
02
Drugs
tegafur
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02813967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813967.